First, we observed that MCC950 reversed breast cancer-induced increased expression of NLRP3 inflammasome-associated genes in astrocytes (Additional file 1: Fig. S6), probably through inhibition of IL-1β and a subsequent feedback effect on priming. This evidence concerns the gene NLRP3 and breast carcinoma.